trial · primary record
Test Estradiol/Levonorgestrel Transdermal Delivery System
Healthy Female Participants
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 68 |
| Primary completion | 2026-09-29 |
| Primary endpoint | Maximum Plasma Concentration (Cmax) of Baseline-Corrected Estradiol |
| Registry ID | NCT07851649 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:40.583Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07851649
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.